HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yao Xu Selected Research

myocardin

1/2021MBNL1 regulates isoproterenol-induced myocardial remodelling in vitro and in vivo.
1/2020LncRNA-Mhrt regulates cardiac hypertrophy by modulating the miR-145a-5p/KLF4/myocardin axis.
1/2019Possible mechanism of GATA4 inhibiting myocardin activity during cardiac hypertrophy.
1/2019MiR-466h-5p induces expression of myocardin with complementary promoter sequences.
1/2018The mechanism of myocardial hypertrophy regulated by the interaction between mhrt and myocardin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yao Xu Research Topics

Disease

46Neoplasms (Cancer)
10/2022 - 01/2016
18Inflammation (Inflammations)
01/2022 - 06/2009
16Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 10/2017
13Hypertension (High Blood Pressure)
06/2022 - 02/2011
12Fibrosis (Cirrhosis)
06/2022 - 01/2015
11Cardiomegaly (Heart Hypertrophy)
01/2022 - 01/2017
9Atherosclerosis
12/2022 - 10/2018
9Neoplasm Metastasis (Metastasis)
01/2022 - 01/2017
8Heart Failure
01/2022 - 06/2009
8Myocardial Infarction
12/2021 - 06/2009
7Hypoxia (Hypoxemia)
11/2020 - 11/2015
6Infections
05/2022 - 10/2019
6Hypertrophy
10/2021 - 01/2017
6Breast Neoplasms (Breast Cancer)
06/2021 - 08/2019
6Melanoma (Melanoma, Malignant)
06/2021 - 01/2017
6Mitochondrial Diseases (Mitochondrial Disease)
01/2021 - 06/2018
5Body Weight (Weight, Body)
01/2021 - 05/2015
5Cardiotoxicity
01/2021 - 01/2018
4Hepatocellular Carcinoma (Hepatoma)
08/2022 - 10/2017
4Aortic Dissection
01/2022 - 10/2018
4COVID-19
12/2021 - 11/2020
4Kidney Diseases (Kidney Disease)
01/2021 - 05/2015
4Reperfusion Injury
01/2021 - 01/2015
4Carcinogenesis
09/2019 - 03/2004
3Necrosis
10/2022 - 07/2017
3Atherosclerotic Plaque (Atheroma)
09/2022 - 01/2020
3Adenocarcinoma
01/2022 - 01/2021
3Dementia (Dementias)
01/2022 - 10/2021
3Coronary Stenosis (Coronary Artery Stenosis)
12/2021 - 09/2017
3Sepsis (Septicemia)
07/2021 - 09/2020
3Hemorrhage
01/2021 - 01/2006
3Obesity
01/2021 - 12/2013
3Critical Illness (Critically Ill)
01/2021 - 10/2017
3Ischemia
11/2020 - 11/2016
3Carcinoma (Carcinomatosis)
10/2020 - 01/2018
3Coronary Artery Disease (Coronary Atherosclerosis)
05/2020 - 09/2017
3Acute Kidney Injury (Acute Renal Failure)
01/2020 - 01/2017
3Heart Diseases (Heart Disease)
01/2019 - 01/2017
3Lung Diseases (Lung Disease)
10/2018 - 01/2017
2Vascular Calcification
12/2022 - 01/2018
2Metabolic Syndrome (Dysmetabolic Syndrome X)
06/2022 - 03/2012
2Ureteral Obstruction
06/2022 - 01/2018
2Osteosarcoma (Osteogenic Sarcoma)
01/2022 - 01/2019
2Cardiomyopathies (Cardiomyopathy)
01/2022 - 12/2021
2Lupus Nephritis
01/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
11/2021 - 06/2010
17CytokinesIBA
01/2022 - 06/2009
16Biomarkers (Surrogate Marker)IBA
10/2021 - 11/2014
10Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 11/2016
9Pharmaceutical PreparationsIBA
01/2022 - 09/2014
8Messenger RNA (mRNA)IBA
06/2021 - 03/2004
7Long Noncoding RNAIBA
08/2022 - 11/2015
7Immune Checkpoint InhibitorsIBA
01/2022 - 12/2017
7Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2017
7VaccinesIBA
10/2021 - 01/2018
7InterleukinsIBA
05/2021 - 06/2018
6MicroRNAs (MicroRNA)IBA
06/2021 - 11/2014
6Interleukin-22 (IL-22)IBA
05/2021 - 01/2017
6AntigensIBA
10/2019 - 01/2017
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2021 - 06/2009
5myocardinIBA
01/2021 - 01/2018
5Angiotensin IIIBA
01/2018 - 06/2009
4LigandsIBA
01/2022 - 01/2018
4InflammasomesIBA
12/2021 - 01/2018
4Interleukin-17 (Interleukin 17)IBA
11/2021 - 01/2017
4LipidsIBA
07/2021 - 09/2020
4Biological ProductsIBA
02/2021 - 01/2018
4RNA (Ribonucleic Acid)IBA
01/2021 - 05/2016
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 06/2018
4Sirolimus (Rapamycin)FDA Link
11/2020 - 11/2016
3Apolipoproteins E (ApoE)IBA
12/2022 - 01/2021
3Eosine Yellowish-(YS) (Eosin)IBA
09/2022 - 01/2021
3Hematoxylin (Haematoxylon)IBA
09/2022 - 01/2021
3L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2022 - 10/2020
3AntioxidantsIBA
12/2021 - 01/2015
3interleukin 20 (IL-20)IBA
12/2021 - 11/2020
3Interleukin-23 (Interleukin 23)IBA
11/2021 - 01/2020
3Intravenous Immunoglobulins (IVIG)FDA Link
11/2021 - 08/2017
3LipopolysaccharidesIBA
07/2021 - 01/2020
3Mitogen-Activated Protein KinasesIBA
06/2021 - 01/2017
3Photosensitizing Agents (Photosensitizers)IBA
04/2021 - 10/2019
3EnzymesIBA
01/2021 - 12/2019
3Interleukin-12 Subunit p35IBA
01/2020 - 09/2018
3Interleukin-12 (IL 12)IBA
01/2020 - 01/2019
3Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
01/2019 - 11/2018
3Transforming Growth Factors (Transforming Growth Factor)IBA
11/2018 - 11/2015
3HDL LipoproteinsIBA
01/2018 - 12/2013
21- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
10/2022 - 06/2018
2Fibronectins (Fibronectin)IBA
06/2022 - 01/2022
2Polysaccharides (Glycans)IBA
05/2022 - 01/2020
2Indicators and Reagents (Reagents)IBA
05/2022 - 01/2021
2Docetaxel (Taxotere)FDA Link
01/2022 - 09/2019
2MetalsIBA
01/2022 - 11/2021

Therapy/Procedure

23Therapeutics
01/2022 - 01/2015
10Drug Therapy (Chemotherapy)
01/2022 - 09/2014
9Immunotherapy
11/2021 - 12/2017
4Artificial Respiration (Mechanical Ventilation)
01/2021 - 01/2017
3Subacute Care
01/2022 - 10/2021
3Precision Medicine
01/2022 - 10/2019
3Surgical Instruments (Clip)
03/2014 - 02/2011